Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells

Journal of Virology

Volumn 83, Issue 7, 2009, Pages 3298-3311

  Larrea, Esther ^a,c   Aldabe, Rafael ^a   Gonzalez, Iranzu ^a,b   Segura, Victor ^a   Sarobe, Pablo ^a   Echeverria, Itziar ^a   Prieto, Jesus ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Digna Biotech   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; JANUS KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOSTATIN M; PEPTIDE; RECOMBINANT ALPHA2 INTERFERON; RECOMBINANT INTERLEUKIN 6; STAT1 PROTEIN; STAT3 PROTEIN; VIRUS ANTIGEN; INTERFERON; JAK1 PROTEIN, HUMAN; STAT1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; ARTICLE; CHEMOSENSITIZATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG POTENTIATION; EFFECTOR CELL; EPITHELIUM CELL; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; BIOSYNTHESIS; IMMUNOLOGY; LIVER; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE; TUMOR CELL LINE;

HEPATITIS C VIRUS;

CELL LINE, TUMOR; EPITHELIAL CELLS; HEPACIVIRUS; HEPATITIS A VIRUS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE I; INTERLEUKIN-15; JANUS KINASE 1; LIVER; LYMPHOCYTE ACTIVATION; ONCOSTATIN M; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES;

EID: 63149088278     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02167-08     Document Type: Article

References (56)

1. Auguste, P., C. Guillet, M. Fourcin, C. Olivier, J. Veziers, A. Pouplard-Barthelaix, and H. Gascan. 1997. Signaling of type II oncostatin M receptor. J. Biol. Chem. 272:15760-15764.
2. Borden, E. C, G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff, G. R. Foster, and G. R. Stark. 2007. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drag Discov. 6:975-990.
3. Castelruiz, Y., E. Larrea, P. Boya, M. P. Civeira, and J. Prieto. 1999. Inter-feron alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls. Hepa-tology 29:1900-1904.
4. Cross, A., S. W. Edwards, R. C. Bucknall, and R. J. Moots. 2004. Secretion of oncostatin M by neutrophils in rheumatoid arthritis. Arthritis Rheum. 50:1430-1436.
5. Curtsinger, J. M., J. O. Valenzuela, P. Agarwal, D. Lins, and M. F. Mescher. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174:4465- 4469.
6. Chatterjee-Kishore, M., K. L. Wright, J. P. Ting, and G. R. Stark. 2000. How Statl mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 19:4111-4122.
7. Chou, T. C, and P. Talalay. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drags or enzyme inhibitors. Adv. Enzyme Regul. 22:27-55.
8. David, M. 2002. Signal transduction by type I interferons. BioTechniques 2002(Suppl.):58-65.
9. de Veer, M. J., M. Holko, M. Frevel, E. Walker, S. Der, J. M. Paranjape, R. H. Silverman, and B. R. Williams. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912-920.
10. Diamond, M. S., D. E. Staunton, S. D. Marlin, and T. A Springer. 1991. Binding of the integrin Mac-1 (CDllb/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65:961-971.
11. Dinarello, C. A., and S. H. Kim. 2006. IL-32, a novel cytokine with a possible role in disease. Ann. Rheum. Dis. 65:61-64.
12. Dubois, S., J. Mariner, T. A. Waldmann, and Y. Tagaya. 2002. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 17:537-547.
13. Ernst, M., and B. J. Jenkins. 2004. Acquiring signalling specificity from the cytokine receptor gpl30. Trends Genet. 20:23-32.
14. Fehling, H. J., W. Swat, C. Laplace, R. Kuhn, K. Rajewsky, U. Muller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the protea-some subunit LMP-7. Science 265:1234-1237.
15. Gannage, M, A, Buzyn, S. I. Bogiatzi, M. Lambert, V. Soumelis, L. Dal Cortivo, M. Cavazzana-Calvo, N. Brousse, and S. Caillat-Zucman. 2008. Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease. Transplantation 85:911-915.
16. Garcia-Sastre, A., and C. A. Biron. 2006. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312:879-882.
17. + T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J. Exp. Med. 204:2591-2602.
18. Grenier, A., M. Dehoux, A. Boutten, M. Arce-Vicioso, G. Durand, M. A. Gougerot-Pocidalo, and S. Chollet-Martin. 1999. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93:1413-1421.
19. Heinrich, P. C, I. Behrmann, G. Muller-Newen, F. Schaper, and L. Graeve. 1998. Interleukin-6-type cytokine signalling through the gpl30/Jak/STAT pathway. Biochem. J. 334:297-314.
20. Hurst, S. M., R. M. McLoughlin, J. Monslow, S. Owens, L. Morgan, G. M. Fuller, N. Topley, and S. A, Jones. 2002. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J. Immunol. 169:5244-5251.
21. Irizarry, R. A., B. M. Bolstad, F. Collin, L. M. Cope, B. Hobbs. and T. P. Speed. 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31:15.
22. Katze, M. G., J. L. Fornek, R. E. Palermo, K. A. Walters, and M. J. Korth. 2008. Innate immune modulation by RNA viruses: emerging insights from functional genomics. Nat. Rev. Immunol. 8:644-654.
23. Kishimoto, T., S. Akira, M. Narazaki, and T. Taga. 1995. Interleukin-6 family of cytokines and gpl30. Blood 86:1243-1254.
24. + T cells. J. Immunol. 180:4391-4401.
25. Kurash, J. K., C. N. Shen, and D. Tosh. 2004. Induction and regulation of acute phase proteins in transdifferentiated hepatocytes. Exp. Cell Res. 292: 342-358.
26. Larrea, E., R. Aldabe, E. Molano, C. M. Fernandez-Rodriguez, A. Ametza-zurra, M. P. Civeira, and J. Prieto. 2006. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies. Gut 55:1188-1196.
27. Larrea, E., R. Aldabe, J. I. Riezu-Boj, A. Guitart, M. P. Civeira, J. Prieto, and E. Baixeras. 2004. IFN-a5 mediates stronger Tyk2-Stat-dependent activation and higher expression of 2′,5′-oligoadenylate synthetase than IFN-α2 in liver cells. J. Interferon Cytokine Res. 24:497-503.
28. Le Bon, A., and D. F. Tough. 2008. Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev. 19:33-40.
29. Li, W., A, E. Sama, and H. Wang. 2006. Role of HMGB1 in cardiovascular diseases. Curr. Opin. Pharmacol. 6:130-135.
30. MacDonald, M. R., E. S. Machlin, O. R. Albin, and D. E. Levy. 2007. The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses. J. Virol. 81:13509-13518.
31. Malik, N, J. C. Kallestad, N. L. Gunderson, S. D. Austin, M. G. Neubauer, V. Ochs, H. Marquardt, J. M. Zarling, M. Shoyab, C. M. Wei, et al. 1989. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol. Cell. Biol. 9:2847-2853.
32. Mosley, B., C. De Imus, D. Friend, N. Boiani, B. Thoma, L. S. Park, and D. Cosman. 1996. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem. 271:32635-32643.
33. Niesporek, S., C. G. Meyer, P. G. Kremsner, and J. May. 2005. Polymorphisms of transporter associated with antigen processing type 1 (TAP1), proteasome subunit beta type 9 (PSMB9) and their common promoter in African children with different manifestations of malaria. Int. J. Immuno-genet. 32:7-11.
34. O'Neill, L. A., and A, G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353-364.
35. Parameswaran, N., R. Suresh, V. Bal, S. Rath, and A, George. 2005. Lack of ICAM-1 on APCs during T cell priming leads to poor generation of central memory cells. J. Immunol. 175:2201-2211.
36. Parmar, S., and L. C. Platanias. 2003. Interferons: mechanisms of action and clinical applications. Curr. Opin. Oncol. 15:431-439.
37. Pichlmair, A., and C. Reis e Sousa. 2007. Innate recognition of viruses. Immunity 27:370-383.
38. Pietschmann, T., V. Lohmann, A. Kaul, N. Krieger, G. Rinck, G. Rutter, D. Strand, and R. Bartenschlager. 2002. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 76:4008-4021.
39. Piqueras, B., J. Connolly, H. Freitas, A. K. Palucka, and J. Banchereau. 2006. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107:2613-2618.
40. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon-medi-ated signalling. Nat. Rev. Immunol. 5:375-386.
41. Rizvi, S. M., and M. Raghavan. 2006. Direct peptide-regulatable interactions between MHC class I molecules and tapasin. Proc. Natl. Acad. Sci. USA 103:18220-18225.
42. + T-regulatory cells. J. Immunother. 29:313-319.
43. + T cells by dendritic cells expressing hepatitis C virus core and El proteins. J. Virol. 76:5062-5070.
44. Shin, E. C, U. Seifert, T. Kato, C. M. Rice, S. M. Feinstone, P. M. Kloetzel, and B. Rehermann. 2006. Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection. J. Clin. Investig. 116:3006-3014.
45. Smyth, G. K. 2005. Limma: linear models for microarray data, p. 397-420. In R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, and W. Huber (ed.), Bioin-formatics and computational biology solutions using R and Bioconductor. Springer, New York, NY.
46. Strehl, B., U. Seifert, E. Kruger, S. Heink, U. Kuckelkorn, and P. M. Kloetzel. 2005. Interferon-gamma, the functional plasticity of the ubiquitin-pro-teasome system, and MHC class I antigen processing. Immunol. Rev. 207: 19-30.
47. Suda, T., K. Chida, A, Todate, K. Ide, K. Asada, Y. Nakamura, K. Suzuki, H. Kuwata, and H. Nakamura. 2002. Oncostatin M production by human dendritic cells in response to bacterial products. Cytokine 17:335-340.
48. Uematsu, S, and S. Akira. 2007. Toll-like receptors and Type I interferons. J. Biol. Chem. 282:15319-15323.
49. Van den Eynde, B. J., and S. Morel. 2001. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoprotea-some. Curr. Opin. Immunol. 13:147-153.
50. Van Kaer, L., P. G. Ashton-Rickardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A, L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1:533-541.
51. Veals, S. A., C. Schindler, D. Leonard, X. Y. Fu, R. Aebersold, J. E. Darnell, Jr., and D. E. Levy. 1992. Subunit of an alpha-interferon- responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol. Cell. Biol. 12:3315-3324.
52. Verhoeckx, K. C, R. P. Doornbos, R. F. Witkamp, J. van der Greef, and R. J. Rodenburg. 2006. Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages. Int. Immunopharmacol. 6:1-7.
53. Vogl, T., K. Tenbrock, S. Ludwig, N. Leukert, C. Ehrhardt, M. A. van Zoelen, W. Nacken, D. Foell, T. van der Poll, C. Sorg, and J. Roth. 2007. Mrp8 and Mrpl4 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13:1042-1049.
54. Yang, C. H., A, Murti, and L. M. Pfeffer. 1998. STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc. Natl. Acad. Sci. USA 95:5568-5572.
55. Zhang, B., S. Kirov, and J. Snoddy. 2005. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33:W741-W748.
56. Zhang, J., S. C. Das, C. Kotalik, A. K. Pattnaik, and L. Zhang. 2004. The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes. J. Biol. Chem. 279: 46335-46342.